Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative DiscographyConclusions Illustrate Nociscan Saves $1,712 per Patient and Improves ...

Shares of ACON opened at $0.77 on Tuesday. The stock has a fifty day moving average price of $2.88 and a two-hundred day moving average price of $36.87. Aclarion has a 52-week low of $0.61 and a ...

April 09, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented ...